Good news for experimental concept but bad news for clinically effective therapy

Circulation

Volumn 99, Issue 2, 1999, Pages 198-200

  Reimer, K A ^a   Califf, R M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Drugs; Editorials; Mibefradil; Myocardial infarction; Trials

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; MIBEFRADIL; NIFEDIPINE; VERAPAMIL;

CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INOTROPISM; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REPERFUSION INJURY; RISK BENEFIT ANALYSIS; TORSADE DES POINTES;

EID: 0032903547     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.2.198     Document Type: Editorial

References (20)